These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10157425)

  • 21. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of health promotion: friend or foe?
    Richardson J
    Aust N Z J Public Health; 1998 Apr; 22(2):247-53. PubMed ID: 9744186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research findings and strategies for assessing telemedicine costs.
    Reardon T
    Telemed J E Health; 2005 Jun; 11(3):348-69. PubMed ID: 16035931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis in heart disease, Part I: General principles.
    Kupersmith J; Holmes-Rovner M; Hogan A; Rovner D; Gardiner J
    Prog Cardiovasc Dis; 1994; 37(3):161-84. PubMed ID: 7972851
    [No Abstract]   [Full Text] [Related]  

  • 25. Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
    Luchini S; Protière C; Moatti JP
    Health Econ; 2003 Jan; 12(1):51-64. PubMed ID: 12483760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group.
    Weinstein MC; Siegel JE; Garber AM; Lipscomb J; Luce BR; Manning WG; Torrance GW
    Health Econ; 1997; 6(5):505-10. PubMed ID: 9353651
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness analysis for health communication programs.
    Guilkey DK; Hutchinson P; Lance P
    J Health Commun; 2006; 11 Suppl 2():47-67. PubMed ID: 17148099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.
    Hoch JS; Briggs AH; Willan AR
    Health Econ; 2002 Jul; 11(5):415-30. PubMed ID: 12112491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes research in health care: simulations to drive cost conclusions.
    Frear R; Motheral B
    Value Health; 2004; 7(1):11-2. PubMed ID: 14720126
    [No Abstract]   [Full Text] [Related]  

  • 30. Methodological limitations of economic evaluations of antenatal screening.
    Petrou S
    Health Econ; 2001 Dec; 10(8):775-8. PubMed ID: 11747056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of indirect costs on outcomes of health care programs.
    Koopmanschap MA; Rutten FF
    Health Econ; 1994; 3(6):385-93. PubMed ID: 9435921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical issues in cost-effectiveness analyses.
    Thompson S
    Stat Methods Med Res; 2002 Dec; 11(6):453-4. PubMed ID: 12516983
    [No Abstract]   [Full Text] [Related]  

  • 33. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation. Part 1: Introduction to the concepts of economic evaluation in health care.
    McIntosh E; Luengo-Fernandez R
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):107-12. PubMed ID: 16824302
    [No Abstract]   [Full Text] [Related]  

  • 36. Time preference, the discounted utility model and health.
    Bleichrodt H; Gafni A
    J Health Econ; 1996 Feb; 15(1):49-66. PubMed ID: 10157428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian estimation of cost-effectiveness ratios from clinical trials.
    Heitjan DF; Moskowitz AJ; Whang W
    Health Econ; 1999 May; 8(3):191-201. PubMed ID: 10348414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of health producing measures across different sectors.
    Drummond M; Stoddart G
    Health Policy; 1995 Sep; 33(3):219-31. PubMed ID: 10145123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic foundations of cost-effectiveness analysis.
    Garber AM; Phelps CE
    J Health Econ; 1997 Feb; 16(1):1-31. PubMed ID: 10167341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative application of econometric frontier and DEA methods for assessing cost efficiency of Finnish hospitals.
    Linna M; Häkkinen U
    Dev Health Econ Public Policy; 1998; 6():169-87. PubMed ID: 10662403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.